A source-linked view of 29 news records gathered from STAT News (health AI, headlines). This page tracks what entered the ethics.ai source fleet; it is not a complete archive of the publisher and does not imply its endorsement.
last source check succeeded. The source is configured on a daily cadence and was last checked 54m ago.
Topic labels are automatic and can be imperfect. Counts measure records captured by ethics.ai, not everything the publisher produced, readership, importance or agreement with a claim.
In this edition of STAT's AI Prognosis: The messy reality of hastily developing and selling AI tools to clinics, and other health AI news.
Commure wants to automate health care's administrative tasks with AI. An inside look at the messy realities of the startup's ambitious quest.
Nurses, who make up the largest part of the health care workforce, say clinical artificial intelligence poses a threat to their jobs, and patients.
Boston, with its rising costs, high taxes, and business climate, is losing ground to rivals across the country, sometimes even in biotech.
“AI is not the villain here; it is a mirror,” reflecting the diminishment of physician judgment, writes former surgeon Frances Mei Hardin.
Federal health officials invited tech companies and lobbyists to closed-door meetings as they seek to boost adoption of clinical AI.
In this edition of STAT's AI Prognosis: Why Schrödinger CEO Ramy Farid is rethinking AI, Recursion's neuron map, and more health AI news.
The leaders of the Federation of State Medical Boards weigh in on the question of licensing AI to practice medicine.
Educators want future physicians to be fluent in AI scribes, but they worry what off-loading clinical notes to AI could do to learning.
In this edition of AI Prognosis: A conversation about benchmarking leading clinical chatbots, investor view on AI in biopharma, and more.
As LLMs compete for doctors' attention, some developers say the science of benchmarking their AI tools for safety and accuracy is flawed.
Senior leaders must treat AI governance as their own daily job, not something the technology committee handles quarterly, write Peter Pronovost, Justin Norden, and Kedar Mate.
Ambient scribe developer Nabla said Brian Manning will be the Paris-based company's new CEO as it looks to grow in a highly competitive market.
Bristol Myers Squibb is the third drugmaker in nine months to announce it is building the largest AI supercomputer in the life sciences industry.
The Trump administration is testing the use of AI in Medicare to approve some medical services.
CMS wants to build a standardized payment structure for clinical software and AI that factors in their impact on patient outcomes.
In this AI Prognosis news roundup: Mayo's AI whistleblower, Sutter Health's reply to lawsuit over Abridge scribe, and more.
Deepfakes undermine the credibility that makes digital care — from telehealth visits to patient portals — possible.
The results of a recent AI competition show that better data trumps bigger models when it comes to predicting properties of drug candidates.
“AI will reshape medicine. The physicians who answer for the outcome must lead the way it enters patient care," write Afnan R. Tariq and Ami Bhatt.
ethics.ai stores source metadata, short summaries and links to the original publisher. It does not republish full articles. Use the permanent evidence link for citation, retain the original source link, and verify consequential claims with the publisher. See the methodology and corrections policy and reuse terms.